7725-93-1Relevant articles and documents
Synthesis, X-ray analysis, biological evaluation and molecular docking study of new thiazoline derivatives
Mabkhot, Yahia N.,Algarni,Alsayari, Abdulrhman,Muhsinah, Abdullatif Bin,Kheder, Nabila A.,Almarhoon, Zainab M.,Al-Aizari, Faiz A.
, (2019/05/24)
A series of new thiazoline derivatives were synthesized. Structure analyses were accomplished employing1H-NMR,13C-NMR, X-ray and MS techniques. The in vitro antitumor activities were assessed against human hepatocellular carcinoma (HepG-2) and colorectal carcinoma (HCT-116) cell lines. The results revealed that the thiazolines 5b and 2c exhibited significant activity against the two cell lines. The in vitro antimicrobial screening showed that the thiazolines 2c, 5b and 5d showed promising inhibition activity against Salmonella sp. Additionally, the inhibition activity of thiazolines 2e and 5b against Escherichia coli was comparable to that of the reference compound gentamycin.
Azole derivatives as histamine H3 receptor antagonists, Part 2: C-C and C-S coupled heterocycles
Walter,Isensee,Kottke,Ligneau,Camelin,Schwartz,Stark
scheme or table, p. 5883 - 5886 (2010/11/18)
With a small series of compounds we demonstrated the variability in the core region of the human histamine H3 receptor (hH3R) antagonist structural blueprint by introducing polar azole groups (oxazole, oxadiazole, thiazole and triazole). Additional variations achieved by coupling different residues to the heterocyclic core structure led to further optimisation of in vitro receptor binding of the novel azole derivatives.
A facile synthesis of thiazole-2(3H)-thiones through [hydroxy(tosyloxy) iodo]benzene
Aggarwal, Ranjana,Pundeer, Rashmi,Kumar, Vinod,Chaudhri, Vishwas,Singh, Shiv P.,Prakash, Om
, p. 2659 - 2664 (2007/10/03)
A one-pot facile synthesis of thiazole-2(3H)-thiones (4) has been achieved by hypervalent iodine oxidation of ketones (1) using [hydroxy (tosyloxy)iodo]benzene, followed by the treatment of the reaction mixture with dithiocarbamate salts (3) The intermediate α-tosyloxy-ketones (2) have also been isolated and converted to the target compounds.